📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy. (2015)

First Author: Plumpton CO

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/epi.12937

PubMed Identifier: 26046144

Publication URI: http://europepmc.org/abstract/MED/26046144

Type: Journal Article/Review

Volume: 56

Parent Publication: Epilepsia

Issue: 4

ISSN: 0013-9580